Ipsen S.A.
General ticker "IPSEF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $9.3B (TTM average)
Ipsen S.A. follows the US Stock Market performance with the rate: 12.4%.
Estimated limits based on current volatility of 0.3%: low 183.08$, high 183.68$
Factors to consider:
- Company pays dividends (annually): last record date 2026-06-04, amount 1.86$ (Y1.01%)
Short-term IPSEF quotes
Long-term IPSEF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €3,306.40MM | €3,574.50MM | €3,674.52MM |
| Operating Expenses | €2,490.40MM | €3,077.80MM | €2,928.50MM |
| Operating Income | €816.00MM | €496.70MM | €746.02MM |
| Non-Operating Income | €-59.90MM | €-64.50MM | €-168.04MM |
| Interest Expense | €37.70MM | €23.80MM | €36.09MM |
| R&D Expense | €619.30MM | €686.60MM | €754.00MM |
| Income(Loss) | €756.10MM | €432.20MM | €577.98MM |
| Taxes | €136.20MM | €74.90MM | €133.55MM |
| Net Income(Loss)* | €617.10MM | €345.90MM | €444.33MM |
| Stockholders Equity | €3,825.10MM | €4,181.60MM | €4,334.28MM |
| Inventory | €289.50MM | €285.50MM | €256.50MM |
| Assets | €6,322.90MM | €6,439.00MM | €6,935.20MM |
| Operating Cash Flow | €865.90MM | €915.50MM | €1,137.97MM |
| Capital expenditure | €182.90MM | €782.50MM | €105.26MM |
| Investing Cash Flow | €-1,078.20MM | €-676.60MM | €-614.97MM |
| Financing Cash Flow | €-435.80MM | €-100.00MM | €298.29MM |
| Earnings Per Share** | €7.40 | €4.32 | €5.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.